Targeting Historically Refractory Interfaces: A Partnership Model that Accelerates Drug Discovery within an Expanded Haystack
Author:
- 1 July 2009
- journal article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 1 (4) , 577-581
Abstract
No abstract availableFunding Information
- National Institutes of Health (AR054442-02)
This publication has 55 references indexed in Scilit:
- Improved insights into the transcriptomes of the human hookworm Necator americanus — Fundamental and biotechnological implicationsBiotechnology Advances, 2009
- targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysisBMC Systems Biology, 2008
- Druggable Targets and Targeted Drugs: Enhancing the Development of New TherapeuticsPharmacology, 2008
- Structural genomics and drug discovery: all in the familyCurrent Opinion in Chemical Biology, 2008
- Systems BiologyDrugs in R&D, 2008
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- DrugBank: a comprehensive resource for in silico drug discovery and explorationNucleic Acids Research, 2006
- The Sequence of the Human GenomeScience, 2001
- Drug Discovery: A Historical PerspectiveScience, 2000
- Drug discovery today – and tomorrowDrug Discovery Today, 2000